[1]王晓芳 魏飞宇 范洁.无导线起搏器植入右心室不同部位的研究[J].心血管病学进展,2025,(4):298.[doi:10.16806/j.cnki.issn.1004-3934.2025.04.003]
　WANG Xiaofang,WEI Feiyu,FAN Jie.Study on The Implantation of L eadless P acemaker in Different Parts of R ight Ventricle[J].Advances in Cardiovascular Diseases,2025,(4):298.[doi:10.16806/j.cnki.issn.1004-3934.2025.04.003]
点击复制

无导线起搏器植入右心室不同部位的研究()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2025年4期
页码:
298
栏目:
综述
出版日期:
2025-04-25

文章信息/Info

Title:
Study on The Implantation of L eadless P acemaker in Different Parts of R ight Ventricle
作者:
王晓芳1 魏飞宇 1; 2 范洁 1; 2
(1.昆明理工大学医学院,云南 昆明 650100;2.云南省第一人民医院心血管内科,云南 昆明 650100)
Author(s):
WANG Xiaofang1; WEI Feiyu 1; 2; FAN Jie1; 2
?1.School of Medicine,Kunming University of Science and Technology,Kunming 650100,Yunnan,China;2.Department of Cardiology,The First People’s Hospital of Yunnan Province,Kunming 650100,Yunnan,China)
关键词:
无导线起搏器; 植入部位; 右室间隔部; 右心室心尖部; 右心室流出道
Keywords:
Leadless pacemaker; Implanting sites; Right ventricular septum; Right ventricular apex; Right ventricular outflow tract
DOI:
10.16806/j.cnki.issn.1004-3934.2025.04.003
摘要:
无导线起搏器的诞生是心血管领域的一大进步，有效弥补了传统经静脉起搏器囊袋感染及导线相关并发症的不足。目前推荐的无导线起搏器首选植入位置为右室间隔部，但关于无导线起搏器植入位置的研究仍为热点。现综述无导线起搏器植入右心室不同部位的研究，评估无导线起搏器植入右心室的最佳位置及并发症的发生情况。
Abstract:
The advent of leadless pacemaker s represents a significant advancement in cardiovascular medicine,effectively addressing the limitations of traditional transvenous pacemakers such as pocket infection s and lead-related complications. While the right ventricular septum is currently recommended as the primary implantation site for leadless pacemaker s,research on optimal device positioning remains an active area of investigation.This article reviews the studies on the implantation of leadless pacemaker s in different sites of the right ventricle,aiming to evaluate the optimal implantation sites and the incidence of associated complications

参考文献/References:

[1].Beck H,Boden WE,Patibandla S,et al. 50th Anniversary of the first successful permanent pacemaker implantation in the United States:historical review and future directions[J]. Am J Cardiol,2010,106(6):810-818.
[2].Duray GZ,Ritter P,El-Chami M,et al. Micra Transcatheter Pacing Study Group. Long-term performance of a transcatheter pacing system:12-Month results from the Micra Transcatheter Pacing Study[J]. Heart Rhythm,2017,14(5):702-709.
[3].Tjong FVY,Knops RE,Udo EO,et al. Leadless pacemaker versus transvenous single-chamber pacemaker therapy:a propensity score-matched analysis[J]. Heart Rhythm,2018,15(9):1387-1393.
[4].Witt CM,Lenz CJ,Shih HH,et al. Right ventricular pacemaker lead position is associated with differences in long-term outcomes and complications[J]. J Cardiovasc Electrophysiol,2017,28(8):924-930.
[5].中国医师协会心律学专业委员会,中华医学会心电生理和起搏分会. 无导线起搏器临床应用中国专家共识(2022)[J]. 中华心律失常学杂志,2022,26(3):263-271.
[6].Bongiorni MG,Della Tommasina V,Barletta V,et al. Feasibility and long-term effectiveness of a non-apical Micra pacemaker implantation in a referral centre for lead extraction[J]. Europace,2019,21(1):114-120.
[7].Sharma P,Singh Guleria V,Bharadwaj P,et al. Assessing safety of leadless pacemaker (MICRA) at various implantation sites and its impact on paced QRS in Indian population[J]. Indian Heart J,2020,72(5):376-382.
[8].Li QY,Dong JZ,Guo CJ,et al. Initial studies on the implanting sites of high and low ventricular septa using leadless cardiac pacemakers[J]. Ann Noninvasive Electrocardiol,2023,28(4):e13068.
[9].Garweg C,Vandenberk B,Foulon S,et al. Leadless pacing with Micra TPS:a comparison between right ventricular outflow tract,mid-septal,and apical implant sites[J]. J Cardiovasc Electrophysiol,2019,30(10):2002-2011.
[10].Li Y,Xing Q,Xiaokereti J,et al. Right ventriculography improves the accuracy of leadless pacemaker implantation in right ventricular mid-septum[J]. J Interv Card Electrophysiol,2023,66(4):941-949.
[11].Arai H,Mizukami A,Hanyu Y,et al. Leadless pacemaker implantation sites confirmed by computed tomography and their parameters and complication rates[J]. Pacing Clin Electrophysiol,2022,45(2):196-203.
[12].ElRefai M,Menexi C,Abouelasaad M,et al. The application of fluoroscopic criteria to define leadless pacemakers implant position and the effect of location on device performance[J]. Br J Radiol,2023,96(1150):20220788.
[13].Shantha G,Brock J,Singleton M,et al. Anatomical location of leadless pacemaker and the risk of pacing-induced cardiomyopathy[J]. J Cardiovasc Electrophysiol,2023,34(6):1418-1426.
[14].李巧元,郭成军,方冬平,等.心室无导线起搏器植入部位的初步探讨[J].中国心脏起搏与心电生理杂志,2019,33(3):224-228.
[15].Hai JJ,Fang J,Tam CC,et al. Safety and feasibility of a midseptal implantation technique of a leadless pacemaker[J]. Heart Rhythm,2019,16(6):896-902.
[16].Mond HG. The road to right ventricular septal pacing:techniques and tools[J]. Pacing Clin Electrophysiol,2010,33(7):888-898.
[17].Mǎrgulescu AD,Suran BM,Rimba? RC,et al. Accuracy of fluoroscopic and electrocardiographic criteria for pacemaker lead implantation by comparison with three-dimensional echocardiography[J]. J Am Soc Echocardiogr,2012,25(7):796-803.
[18].Kawakami T,Tanaka N,Ohno H,et al. The relationship between right ventricular lead position and paced QRS duration[J]. Pacing Clin Electrophysiol,2013,36(2):187-193.
[19].Moore P,Coucher J,Ngai S,et al. Imaging and right ventricular pacing lead position:a comparison of CT,MRI,and echocardiography[J]. Pacing Clin Electrophysiol,2016,39(4):382-392.
[20].McGavigan AD,Roberts-Thompson KC,Hillock RJ,et al. Right ventricular outflow tract pacing:radiographic and electrocardiographic correlates of lead position[J]. Pacing Clin Electrophysiol,2006,29(10):1063-1068.
[21].Burri H,Domenichini G,Sunthorn H,et al. Comparison of tools and techniques for implanting pacemaker leads on the ventricular mid-septum[J]. Europace,2012,14(6):847-852.
[22].Pang BJ,Joshi SB,Lui EH,et al. Validation of conventional fluoroscopic and ECG criteria for right ventricular pacemaker lead position using cardiac computed tomography[J]. Pacing Clin Electrophysiol ,2014,37(4):495-504.
[23].Tolosana JM,Guasch E,San Antonio R,et al. Very high pacing thresholds during long-term follow-up predicted by a combination of implant pacing threshold and impedance in leadless transcatheter pacemakers[J]. J Cardiovasc Electrophysiol,2020,31(4):868-874.
[24].Nair DG,Exner DV,Reddy VY,et al. Early real-world implant experience with a helix-fixation ventricular leadless pacemaker[J]. J Interv Card Electrophysiol,2024,67(7):1539-1545.
[25].Tam MTK,Cheng YW,Chan JYS,et al. Aveir VR real-world performance and chronic pacing threshold prediction using mapping and fixation electrical data[J]. Europace,2024,26(3):euae051.
[26].Sharma G,Shetkar SS,Patel CD,et al. Paced QRS duration predicts left ventricular function in patients with permanent pacemakers—One-year follow-up study using equilibrium radionuclide angiography (ERNA)[J]. Indian Pacing Electrophysiol J,2015,15(2):90-95.
[27].Miyoshi F,Kobayashi Y,Itou H,et al. Prolonged paced QRS duration as a predictor for congestive heart failure in patients with right ventricular apical pacing[J]. Pacing Clin Electrophysiol,2005,28(11):1182-1188.
[28].Tse HF,Yu C,Wong KK,et al. Functional abnormalities in patients with permanent right ventricular pacing:the effect of sites of electrical stimulation[J]. J Am Coll Cardiol,2002,40(8):1451-1458.
[29].Shukla HH,Hellkamp AS,James EA,et al. Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS duration[J]. Heart Rhythm,2005,2(3):245-251.
[30].Wherry K,Stromberg K,Hinnenthal JA,et al. Using medicare claims to identify acute clinical events following implantation of leadless pacemakers[J]. Pragmat Obs Res,2020,11:19-26.
[31].Hauser RG,Gornick CC,Abdelhadi RH,et al. Major adverse clinical events associated with implantation of a leadless intracardiac pacemaker[J]. Heart Rhythm,2021,18(7):1132-1139.
[32].Reddy VY,Exner DV,Doshi R,et al. Primary results on safety and efficacy from the LEADLESS Ⅱ-Phase 2 worldwide clinical trial[J]. JACC Clin Electrophysiol,2022,8(1):115-117.
[33].Reddy VY,Exner DV,Doshi R,et al. 1-Year outcomes of a leadless ventricular pacemaker:the LEADLESS Ⅱ (Phase 2) trial[J]. JACC Clin Electrophysiol,2023,9(7 Pt 2):1187-1189.

相似文献/References:

[1]马娟 范洁.无导线起搏器与传统起搏器并发症比较[J].心血管病学进展,2022,(9):819.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.013]
　MA Juan,FAN Jie.Comparison of Complications Between Leadless Cardiac Pacemaker and Traditional Pacemaker[J].Advances in Cardiovascular Diseases,2022,(4):819.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.013]
[2]牟秦娇 张玥 王楠.无导线起搏器在特殊人群中植入的研究进展[J].心血管病学进展,2023,(8):694.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.006]
　MOU QinjiaoZHANG YueWANG Nan.Analysis of Implantation of Leadless Pacemakers in Special Populations[J].Advances in Cardiovascular Diseases,2023,(4):694.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.006]
[3]刘晨 牛国栋 郭涛 付明鹏 乔宇 郭雨龙.无导线起搏器单中心临床应用研究[J].心血管病学进展,2025,(1):93.[doi:10.16806/j.cnki.issn.1004-3934.2025.01.019]
　LIU Chen,NIU Guodong,GUO Tao,et al.Clinical Application of Leadless Pacemakers in Single Center[J].Advances in Cardiovascular Diseases,2025,(4):93.[doi:10.16806/j.cnki.issn.1004-3934.2025.01.019]
[4]张能 邢强 汤宝鹏.无导线起搏器植入术后阈值变化的研究进展[J].心血管病学进展,2025,(2):97.[doi:10.16806/j.cnki.issn.1004-3934.2025.02.001]
　ZHANG Neng,XING Qiang,TANG Baopeng.Threshold Changes after Leadless Pacemaker Implantation[J].Advances in Cardiovascular Diseases,2025,(4):97.[doi:10.16806/j.cnki.issn.1004-3934.2025.02.001]

更新日期/Last Update: 2025-05-16